BACKGROUND: Childhood Wilms tumor represents one of the challenge for pediatric oncologists in developing countries. We report the characteristics and treatment results of patients with Wilms tumor according to SIOP 9 protocol in Morocco. PROCEDURE: From January 1989 to December 2000, 86 children with Wilms tumor were admitted. The diagnosis was based on physical exam and abdominal ultrasound. The metastatic work-up was based on abdominal ultrasound and chest X-ray. RESULTS: The mean age was 36 months (3-120 months). The sex-ratio was 1. Abdominal mass was the main symptom at presentation (84 cases). There were 13 metastatic cases. Treatment applied was according to SIOP 9 Protocol without randomization. Local deases was present in 75 patients with stage I in 38 cases (50%), IIN0 in 4 cases (6%), IIN1 in 9 cases, and III in 24 cases (44%). The distribution of pathologic groups was: favorable in 4 cases, standard in 69 cases, and unfavorable anaplastic type in 2 cases. Sixty-nine patients were evaluable for therapeutic evaluation. Other patients were lost to follow-up. Three patients died of treatment related toxicity and 13 patients relapsed. With a median follow-up of 70 months, the 5-year EFS and 5 years overall survival for evaluable patients are 77.4% and 79%, respectively while the 5-year EFS for all patients was 56%. CONCLUSION: These results are encouraging for a developing country but special efforts should be done to reduce the rate of abandonment.
BACKGROUND: Childhood Wilms tumor represents one of the challenge for pediatric oncologists in developing countries. We report the characteristics and treatment results of patients with Wilms tumor according to SIOP 9 protocol in Morocco. PROCEDURE: From January 1989 to December 2000, 86 children with Wilms tumor were admitted. The diagnosis was based on physical exam and abdominal ultrasound. The metastatic work-up was based on abdominal ultrasound and chest X-ray. RESULTS: The mean age was 36 months (3-120 months). The sex-ratio was 1. Abdominal mass was the main symptom at presentation (84 cases). There were 13 metastatic cases. Treatment applied was according to SIOP 9 Protocol without randomization. Local deases was present in 75 patients with stage I in 38 cases (50%), IIN0 in 4 cases (6%), IIN1 in 9 cases, and III in 24 cases (44%). The distribution of pathologic groups was: favorable in 4 cases, standard in 69 cases, and unfavorable anaplastic type in 2 cases. Sixty-nine patients were evaluable for therapeutic evaluation. Other patients were lost to follow-up. Three patients died of treatment related toxicity and 13 patients relapsed. With a median follow-up of 70 months, the 5-year EFS and 5 years overall survival for evaluable patients are 77.4% and 79%, respectively while the 5-year EFS for all patients was 56%. CONCLUSION: These results are encouraging for a developing country but special efforts should be done to reduce the rate of abandonment.
Authors: Paola Friedrich; Roberta Ortiz; Kelly Strait; Soad Fuentes; Yéssica Gamboa; Ingrid Arambú; María Ah-Chu-Sanchez; Wendy London; Carlos Rodríguez-Galindo; Federico Antillón-Klussmann; Fulgencio Báez Journal: Cancer Date: 2012-09-12 Impact factor: 6.860
Authors: Jaime Libes; Oliver Oruko; Fatmah Abdallah; Jessie Githanga; James Ndung'u; Joyce Musimbi; Festus Njuguna; Kirtika Patel; John White; Jason R Axt; James A O'Neill; Martha Shrubsole; Ming Li; Harold N Lovvorn Journal: Pediatr Blood Cancer Date: 2014-11-08 Impact factor: 3.167
Authors: Trijn Israëls; Joyce Kambugu; Francine Kouya; Nader Kim El-Mallawany; Peter B Hesseling; Gertjan J L Kaspers; Tim Eden; Lorna Renner; Elizabeth M Molyneux Journal: Nat Rev Clin Oncol Date: 2013-07-30 Impact factor: 66.675
Authors: Paola Friedrich; Catherine G Lam; Elena Itriago; Rafael Perez; Raul C Ribeiro; Ramandeep S Arora Journal: PLoS One Date: 2015-09-30 Impact factor: 3.240
Authors: Paola Friedrich; Catherine G Lam; Geetinder Kaur; Elena Itriago; Raul C Ribeiro; Ramandeep S Arora Journal: PLoS One Date: 2016-10-13 Impact factor: 3.240
Authors: Ossama M Zakaria; Emad N Hokkam; Karam Al Sayem; Mohamed Yasser I Daoud; Hazem M Zakaria; Fouad Sedky; Seba H Graiz; Saleh A Moussa; Hamed A Al Wadaani Journal: World J Oncol Date: 2015-10-26
Authors: Jeremy S Slone; Amanda K Slone; Oaitse Wally; Pearl Semetsa; Mpho Raletshegwana; Susan Alisanski; Lisa M Force; Kamusisi Chinyundo; Judith Margolin; Anurag K Agrawal; Alan R Anderson; Michael E Scheurer; Parth S Mehta Journal: J Glob Oncol Date: 2018-09
Authors: Bui Ngoc Lan; Anders Castor; Thomas Wiebe; Jacek Toporski; Christian Moëll; Lars Hagander Journal: BMJ Open Date: 2019-08-05 Impact factor: 2.692